PT91597A - Process for treating cutaneous lesions using antagonists of thea2 tromboxan receiver - Google Patents
Process for treating cutaneous lesions using antagonists of thea2 tromboxan receiverInfo
- Publication number
- PT91597A PT91597A PT91597A PT9159789A PT91597A PT 91597 A PT91597 A PT 91597A PT 91597 A PT91597 A PT 91597A PT 9159789 A PT9159789 A PT 9159789A PT 91597 A PT91597 A PT 91597A
- Authority
- PT
- Portugal
- Prior art keywords
- tromboxan
- thea2
- antagonists
- receiver
- cutaneous lesions
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title 1
- 230000003902 lesion Effects 0.000 title 1
- 208000028990 Skin injury Diseases 0.000 abstract 1
- 229940123987 Thromboxane A2 receptor antagonist Drugs 0.000 abstract 1
- 239000003769 thromboxane A2 receptor blocking agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Financial Or Insurance-Related Operations Such As Payment And Settlement (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/239,376 US4925873A (en) | 1988-09-01 | 1988-09-01 | Method of treating skin injuries using thromboxane A2 receptor antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
PT91597A true PT91597A (pt) | 1990-03-30 |
PT91597B PT91597B (pt) | 1995-05-04 |
Family
ID=22901897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT91597A PT91597B (pt) | 1988-09-01 | 1989-08-31 | Processo para tratar lesoes cutaneas usando antagonistas do receptor de tromboxano a2 como o 7-oxabiciclo-{2.2.1}hept-2-1}5-heptenoico |
Country Status (13)
Country | Link |
---|---|
US (1) | US4925873A (pt) |
EP (1) | EP0357030B1 (pt) |
JP (1) | JPH02108635A (pt) |
AT (1) | ATE100320T1 (pt) |
AU (1) | AU632503B2 (pt) |
CA (1) | CA1337930C (pt) |
DE (1) | DE68912459T2 (pt) |
DK (1) | DK175207B1 (pt) |
HU (1) | HUT51137A (pt) |
IE (1) | IE63799B1 (pt) |
NZ (1) | NZ230505A (pt) |
PT (1) | PT91597B (pt) |
ZA (1) | ZA896558B (pt) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6313146B1 (en) | 1991-08-23 | 2001-11-06 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
US5858684A (en) * | 1991-08-23 | 1999-01-12 | The Brigham And Women's Hospital, Inc. | Method of screening calcium receptor-active molecules |
US6001884A (en) * | 1991-08-23 | 1999-12-14 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
US5763569A (en) * | 1991-08-23 | 1998-06-09 | The Brigham And Women's Hospital, Inc | Calcium receptor-active molecules |
US6011068A (en) * | 1991-08-23 | 2000-01-04 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
US5688938A (en) * | 1991-08-23 | 1997-11-18 | The Brigham & Women's Hospital, Inc. | Calcium receptor-active molecules |
US6031003A (en) * | 1991-08-23 | 2000-02-29 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
US5324746A (en) * | 1993-02-12 | 1994-06-28 | Mckee Rex N | Method of treating damaged mucosal and epithelial tissues with misoprostol |
US5962314A (en) * | 1993-02-23 | 1999-10-05 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
US7910624B1 (en) | 1995-03-03 | 2011-03-22 | The Trustees Of Boston University | Compositions for the treatment of blood disorders |
AU696167B2 (en) * | 1993-10-29 | 1998-09-03 | Trustees Of Boston University | Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents |
CA2202879C (en) | 1994-10-21 | 2005-08-30 | Bradford C. Van Wagenen | Calcium receptor-active compounds |
GB9424708D0 (en) * | 1994-12-07 | 1995-02-01 | Bristol Myers Squibb Co | Use of inflammatory modulators in the treatment of chronic or recalcitrant skin damage |
US6011000A (en) * | 1995-03-03 | 2000-01-04 | Perrine; Susan P. | Compositions for the treatment of blood disorders |
ES2201300T3 (es) * | 1996-05-01 | 2004-03-16 | Nps Pharmaceuticals, Inc. | Compuestos activos frente a receptores de iones inorganicos. |
US5994399A (en) * | 1997-03-27 | 1999-11-30 | Mckee; Rex N. | Method of regenerating collagen-containing tissues with misoprostol |
WO1999040883A2 (en) * | 1998-02-11 | 1999-08-19 | Faller Douglas V | Compositions and methods for the treatment of cystic fibrosis |
US7241746B2 (en) * | 2003-08-06 | 2007-07-10 | Regena Therapeutics, Lc | Method and composition for treating periodontal disease |
WO2010105112A1 (en) * | 2009-03-11 | 2010-09-16 | Hemaquest Pharmaceuticals, Inc. | Detection of short-chain fatty acids in biological samples |
US20110086869A1 (en) | 2009-09-24 | 2011-04-14 | The Trustees Of Boston University | Methods for treating viral disorders |
WO2011072086A1 (en) | 2009-12-08 | 2011-06-16 | Hemaquest Pharmaceuticals, Inc. | Methods and low dose regimens for treating red blood cell disorders |
WO2011113013A2 (en) | 2010-03-11 | 2011-09-15 | Hemaquest Pharmaceuticals, Inc. | Methods and compositions for treating viral or virally-induced conditions |
WO2012105823A1 (en) | 2011-02-02 | 2012-08-09 | Biotropics Malaysia Berhad | Cosmetic non therapeutic use of extracts from ficus deltoidea |
JP2022536256A (ja) | 2019-05-31 | 2022-08-15 | ヴィラクタ サブシディアリー,インク. | ヒストンデアセチラーゼ阻害剤を用いてウイルス関連癌を治療する方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2809377A1 (de) * | 1978-03-04 | 1979-09-13 | Boehringer Mannheim Gmbh | Phenoxyalkylcarbonsaeure-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel |
US4311707A (en) * | 1979-02-12 | 1982-01-19 | American Cyanamid Company | Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions |
DE3000377A1 (de) * | 1980-01-07 | 1981-07-09 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel |
US4537981A (en) * | 1981-11-09 | 1985-08-27 | E. R. Squibb & Sons, Inc. | 7-Oxabicycloheptane and 7-oxabicycloheptene compounds |
US4416896A (en) * | 1982-05-17 | 1983-11-22 | E. R. Squibb & Sons, Inc. | 7-Oxabicyclopheptane substituted amino prostaglandin analogs useful in the treatment of thrombolytic disease |
US4663336A (en) * | 1985-07-01 | 1987-05-05 | E. R. Squibb & Sons, Inc. | 7-oxabicycloheptane substituted diamide and its congener prostaglandin analogs useful in the treatment of thrombotic disease |
US4673685A (en) * | 1986-07-23 | 1987-06-16 | E. R. Squibb & Sons, Inc. | Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease |
US4752616A (en) * | 1987-06-29 | 1988-06-21 | E. R. Squibb & Sons, Inc. | Arylthioalkylphenyl carboxylic acids, compositions containing same and method of use |
-
1988
- 1988-09-01 US US07/239,376 patent/US4925873A/en not_active Expired - Fee Related
-
1989
- 1989-08-22 CA CA000609039A patent/CA1337930C/en not_active Expired - Fee Related
- 1989-08-28 ZA ZA896558A patent/ZA896558B/xx unknown
- 1989-08-28 IE IE275589A patent/IE63799B1/en not_active IP Right Cessation
- 1989-08-30 AT AT89116002T patent/ATE100320T1/de not_active IP Right Cessation
- 1989-08-30 DE DE68912459T patent/DE68912459T2/de not_active Expired - Fee Related
- 1989-08-30 EP EP89116002A patent/EP0357030B1/en not_active Expired - Lifetime
- 1989-08-30 AU AU40898/89A patent/AU632503B2/en not_active Ceased
- 1989-08-31 NZ NZ230505A patent/NZ230505A/en unknown
- 1989-08-31 JP JP1228178A patent/JPH02108635A/ja active Pending
- 1989-08-31 HU HU894522A patent/HUT51137A/hu unknown
- 1989-08-31 PT PT91597A patent/PT91597B/pt not_active IP Right Cessation
- 1989-08-31 DK DK198904315A patent/DK175207B1/da not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0357030A2 (en) | 1990-03-07 |
DE68912459D1 (de) | 1994-03-03 |
ATE100320T1 (de) | 1994-02-15 |
AU632503B2 (en) | 1993-01-07 |
ZA896558B (en) | 1990-05-30 |
EP0357030B1 (en) | 1994-01-19 |
JPH02108635A (ja) | 1990-04-20 |
DK431589D0 (da) | 1989-08-31 |
DK175207B1 (da) | 2004-07-12 |
CA1337930C (en) | 1996-01-16 |
US4925873A (en) | 1990-05-15 |
DE68912459T2 (de) | 1994-08-04 |
PT91597B (pt) | 1995-05-04 |
AU4089889A (en) | 1990-03-08 |
DK431589A (da) | 1990-03-02 |
EP0357030A3 (en) | 1990-08-16 |
NZ230505A (en) | 1997-03-24 |
IE63799B1 (en) | 1995-06-14 |
IE892755L (en) | 1990-03-01 |
HUT51137A (en) | 1990-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT91597A (pt) | Process for treating cutaneous lesions using antagonists of thea2 tromboxan receiver | |
DE68929460D1 (de) | Substituierte Phenylpyrimidine Derivate, für die Behandlung oder Prevention von ZNS-Erkrankungen | |
HU912359D0 (en) | The use of flupirtine active agents for treating muscle-tension | |
ES2038609T3 (es) | 4,5-dihidroisoxazol, 3,5 disustituido como inhibidores de transglutaminasa. | |
UA41355C2 (uk) | Засіб для лікування нейро-сніду | |
ATE158183T1 (de) | Arzneimittel zur behandlung von anxietas | |
DK71387A (da) | Terapeutisk middel til behandling af psoriasis | |
DE58907570D1 (de) | Verwendung von bicyclischen Imidazol-Verbindungen zur Behandlung von Hyperaldosteronismus. | |
US4931457B1 (en) | Naphthylamino-and naphthyloxy-pyridineamin compounds useful as topical antiinflammatory agents for the treatment of skin disorders | |
ES2093357T3 (es) | Metodo de tratamiento de la alopecia. | |
ES2180550T3 (es) | Moleculas receptoras de la hormona de glycoproteina. | |
BR9406034A (pt) | Derivados de imidazoloquinoxalinonas como antagonistas de eaa. | |
ES2145608T3 (es) | El empleo de buckminster-fulereno para tratamiento de lesion neurotoxica. | |
DE68912376D1 (de) | Analoge von Bradykinin, dessen Synthese und dessen Benutzung in der Therapie. | |
MX164619B (es) | Composicion para el tratamiento de lesiones cutaneas | |
FI871535A0 (fi) | Menetelmä terapeuttisesti aktiivisten tiasykloalkeno/3,2-b/pyridiinien valmistamiseksi | |
DK277387A (da) | Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom | |
LV10391A (lv) | Alkilfosforskabes savienojumu izmantosana psoriazes tipa slimibu arstesanai | |
HU912638D0 (en) | Transdermal medical device for entering medical active agents under controlled ph-conditions of the skin surface, and process for its production | |
DE3866860D1 (de) | Thyrotropin abgebende hormonanaloge fuer verletzungen am zentralnervensystem. | |
ATE147983T1 (de) | Transdermales therapeutisches system mit pentylentetrazol als wirkstoff | |
ES2190499T3 (es) | Uso de antagonistas de bradiquinina para la preparacion de medicamentos para el tratamiento y la prevencion de la enfermedad de alzheimer. | |
FI97884B (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 3,4-dihydroksi-2,5-dihydrofuranonien valmistamiseksi | |
ATE102828T1 (de) | Verwendung von calciumantagonisten fuer die behandlung von narben. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG3A | Patent granted, date of granting |
Effective date: 19941013 |
|
MM4A | Annulment/lapse due to non-payment of fees, searched and examined patent |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20090413 |
|
MM4A | Annulment/lapse due to non-payment of fees, searched and examined patent |
Free format text: MAXIMUM VALIDITY LIMIT REACHED Effective date: 20091013 |